These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33670031)

  • 1. Osteopontin Levels in Patients with Squamous Metastatic Head and Neck Cancer.
    Maleš J; Mihalj H; Šestak A; Kralik K; Smolić M
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33670031
    [No Abstract]   [Full Text] [Related]  

  • 2. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
    BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality: evidence to support a revision of the American Joint Committee on Cancer staging system.
    Ebrahimi A; Gil Z; Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Kohler HF; Kreppel M; Cernea CR; Brandao J; Bachar G; Bolzoni Villaret A; Fliss D; Fridman E; Robbins KT; Shah JP; Patel SG; Clark JR;
    Cancer; 2014 Jul; 120(13):1968-74. PubMed ID: 24691658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteopontin levels in patients with head and neck cancer undergoing chemoradiotherapy.
    Snitcovsky I; Leitão GM; Pasini FS; Brunialti KC; Mangone FR; Maistro S; de Castro G; Villar RC; Federico MH
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):807-11. PubMed ID: 19687403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma.
    Xing Y; Zhang J; Lin H; Gold KA; Sturgis EM; Garden AS; Lee JJ; William WN
    Cancer; 2016 Feb; 122(4):534-45. PubMed ID: 26554754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
    Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
    Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical evaluation of lymph node ratio in head and neck cancer.
    de Ridder M; Marres CC; Smeele LE; van den Brekel MW; Hauptmann M; Balm AJ; van Velthuysen ML
    Virchows Arch; 2016 Dec; 469(6):635-641. PubMed ID: 27639568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of extracapsular lymph node spread in the ipsilateral neck on contralateral neck metastasis and prognosis of laryngeal cancer].
    Liu B; Guan C; Ji WY; Pan ZM
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):871-5. PubMed ID: 17416015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective neck dissection for node-positive necks in patients with head and neck squamous cell carcinoma: a word of caution.
    Santos AB; Cernea CR; Inoue M; Ferraz AR
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):79-81. PubMed ID: 16415434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of elevated osteopontin levels in head and neck cancer patients.
    Eto M; Kodama S; Nomi N; Uemura N; Suzuki M
    Auris Nasus Larynx; 2007 Sep; 34(3):343-6. PubMed ID: 17254728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.
    O'Brien CJ; McNeil EB; McMahon JD; Pathak I; Lauer CS; Jackson MA
    Head Neck; 2002 May; 24(5):417-22. PubMed ID: 12001070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
    Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
    Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
    León X; Neumann E; Gutiérrez A; García J; López M; Quer M
    Head Neck; 2020 Oct; 42(10):2912-2919. PubMed ID: 32588930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion of extracapsular spread in the pTNM classification system: a proposal for patients with head and neck carcinoma.
    de Juan J; García J; López M; Orús C; Esteller E; Quer M; León X
    JAMA Otolaryngol Head Neck Surg; 2013 May; 139(5):483-8. PubMed ID: 23681031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis].
    Zhao Hongchun ; Wang Yanfei ; Zheng Tihua ; Che Juan ; Cao Ruijuan ; Wang Xia
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1530-3. PubMed ID: 26647537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of contralateral N0 neck in tonsillar squamous cell carcinoma.
    Lim YC; Lee SY; Lim JY; Shin HA; Lee JS; Koo BS; Kim SH; Choi EC
    Laryngoscope; 2005 Sep; 115(9):1672-5. PubMed ID: 16148715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.
    Abdel Razek AAK; Nada N
    Eur Arch Otorhinolaryngol; 2018 May; 275(5):1301-1307. PubMed ID: 29582174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.